LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research financials

Yes. Lam Research earned 8.45B USD of net income over the last twelve months, 32.3% of its revenue. It made a profit in 33 of its 41 fiscal years since 1986. Its last loss was in fiscal year 2009.

Revenue (TTM)
26.13B USD
Net income (TTM)
8.45B USD
Free cash flow (TTM)
6.54B USD
Cash and short-term investments
7.44B USD
Total debt
3.74B USD
Shareholders' equity
13.91B USD

Cash, debt and equity as of 27 Sept 2026.

Lam Research earnings

Next earnings · Q2 FY2027
EPS estimate
2.34 USD
Revenue estimate
8.63B USD
Last quarter · Q1 FY2027
EPS2.20Beat +0.9%Revenue8.22BBeat +1.0%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20283.05———10.57B———
Q2 FY20282.92——+24.74%10.23B——+18.45%
Q1 FY20282.77——+25.71%9.79B——+19.08%
Q2 FY20272.34——+84.25%8.63B——+61.52%
Q1 FY20272.182.20+0.92%+74.60%8.14B8.22B+0.95%+54.38%
Q4 FY20261.691.82+7.69%+36.84%6.66B6.72B+0.86%+29.99%
Q3 FY20261.361.47+8.09%+41.35%5.75B5.84B+1.58%+23.76%
Q2 FY20261.171.27+8.55%+39.56%5.23B5.34B+2.13%+22.14%
Q1 FY20261.221.26+3.28%+46.51%5.22B5.32B+1.93%+27.74%
Q4 FY20251.211.33+9.92%+64.20%5.00B5.17B+3.35%+33.58%

Lam Research growth and profitability

Full income statement
Revenue (TTM)
26.13B USD
Net income (TTM)
8.45B USD
Gross margin
51.05%
Operating margin
36.95%
Net margin
32.34%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202623.23B+26.02%7.27B+35.59%50.47%35.29%31.27%8.70B+37.19%
FY202518.44B+23.68%5.36B+39.98%48.71%32.01%29.06%6.34B+29.34%
FY202414.91B-14.47%3.83B-15.14%47.32%28.61%25.68%4.91B-13.00%
FY202317.43B+1.16%4.51B-2.05%44.63%29.69%25.89%5.64B-1.29%
FY202217.23B+17.78%4.61B+17.83%45.69%31.24%26.73%5.71B+16.88%

How Lam Research makes its money

System14.89B 64.1%
Customer Support and Other8.35B 35.9%
Revenue23.23B 100.0%
Cost of revenue11.51B 49.5%
Gross profit11.73B 50.5%
Research and development2.38B 10.2%
Selling and administration1.15B 4.9%
Operating income8.20B 35.3%
Tax997.08M 4.3%
Net income7.27B 31.3%

FY2026, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Lam Research revenue breakdown

By product

FY2026
System: 64.1%Customer Support and Other: 35.9%64.1%System35.9%Customer Support and Other
SegmentRevenueShare of revenueChange on the year
System14.89B64.1%+29.5%
Customer Support and Other8.35B35.9%+20.2%

By region

FY2026
China: 33.8%Taiwan: 22.5%South Korea: 19.4%Japan: 9.3%United States: 6.6%South East Asia: 5.4%Europe: 3.0%33.8%China22.5%Taiwan19.4%South Korea9.3%Japan6.6%United States5.4%South East Asia3.0%Europe
RegionRevenueShare of revenueChange on the year
China7.86B33.8%+26.7%
Taiwan5.22B22.5%+51.6%
South Korea4.51B19.4%+9.1%
Japan2.17B9.3%+15.4%
United States1.53B6.6%+11.0%
South East Asia1.25B5.4%+48.8%
Europe698.71M3.0%+24.2%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20265.86B4.89B
FY20256.17B5.41B
FY20244.65B4.26B
FY20235.18B4.68B
FY20223.10B2.55B
FY20213.59B3.24B
FY20202.13B1.92B
FY20193.18B2.87B
FY20182.66B2.38B
FY20172.03B1.87B

Lam Research financial health

Full balance sheet
Cash and short-term investments
7.44B USD
Total debt
3.74B USD
Net cash
3.70B USD
Free cash flow (TTM)
6.54B USD
Current ratio
2.48
Debt to equity
0.27
Piotroski score
7 / 9
Altman Z-score
16.78

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20265.58B4.12B4.89B
FY20256.39B4.76B5.41B
FY20245.85B4.98B4.26B
FY20235.37B5.01B4.68B
FY20223.66B5.01B2.55B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202623.53B11.06B12.47B
FY202521.35B11.48B9.86B
FY202418.74B10.21B8.54B
FY202318.78B10.57B8.21B
FY202217.20B10.92B6.28B
FY202115.89B9.86B6.03B
FY202014.56B9.38B5.18B
FY201912.00B7.28B4.72B
FY201812.48B5.90B6.58B
FY201712.12B5.14B6.99B

Lam Research valuation

Price to earnings ratio (TTM)
29.68
Forward P/E (FY2027)
20.75
Price to sales (TTM)
9.60
Price to book
18.03
EV / EBITDA (TTM)
24.27

Capital structure

Market capitalization
250.74B USD
+
Total debt
3.74B USD
−
Cash and short-term investments
7.44B USD
=
Enterprise value
247.03B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2029 (est.)13.86————
FY2028 (est.)16.5313.86———
FY2027 (est.)20.7516.53———
Now (TTM)29.6818.979.6018.0324.27
FY202670.9739.2422.2041.3559.08
FY202523.3417.106.7912.6919.47
FY202436.4526.549.3516.3228.24
FY202318.6319.614.8210.2414.85
FY202213.6713.553.6510.0211.28

Lam Research against its own history

Each figure in the latest fiscal year against the same figure from FY2022 to FY2026: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Texas Instruments, Applied Materials, Intel, Analog Devices, KLA, and QUALCOMM, the US Semiconductors companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median29.7
    9.681.4
  • Gross marginHighest in 5 years50.5%
    44.6%50.5%
    Against its peers: 5 of 7Peers' median 56.2%
  • Operating marginHighest in 5 years35.3%
    28.6%35.3%
    Against its peers: 2 of 7Peers' median 28.6%
  • Net marginHighest in 5 years31.3%
    25.7%31.3%
    Against its peers: 2 of 7Peers' median 22.6%
  • Return on equityAbove its median58.3%
    44.8%73.4%
    Against its peers: 2 of 7Peers' median 28.4%
  • Free cash flow marginBelow its median21.1%
    14.8%29.4%
    Against its peers: 4 of 7Peers' median 23.9%
  • Revenue growthHighest in 5 years26.0%
    -14.5%26.0%
    Against its peers: 1 of 7Peers' median 12.4%
  • EPS growthAbove its median38.8%
    -12.7%43.1%
    Against its peers: 2 of 6Peers' median 4.8%
  • Debt to EBITDALowest in 5 years0.47×
    0.47×1.02×
    Against its peers: 1 of 7Peers' median 1.41×
  • Current ratioBelow its median2.63
    2.213.16
    Against its peers: 4 of 7Peers' median 2.71

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Lam Research dividends

Annual dividend
1.32 USD
Dividend yield (indicated)
0.66%
Payout ratio
16.44%
Years of dividend growth
12
Frequency
Quarterly
Last payment
0.33 USD
Last ex-dividend date
23 Sept 2026
Last payment date
14 Oct 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share0.950.830.720.620.540.480.340.430.180.12

Lam Research ownership

Institutions
86.52%
Institutional holders
3,247 (+515)
Free float
99.50%

Who owns the shares

Institutions 86.5% Others 13.5%
As of 30 Jun 2026

Shares free to trade

Free float 1.25B shares ·99.5% Closely held 6.21M shares ·0.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 20260231.40K64.01K
Q3 202609129.75K318.13K
Q2 20260466.01K146.85K
Q1 202606953.49K1.02M

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY20261.26B1.26B-2.25%
FY20251.29B1.29B-2.26%
FY20241.31B1.32B-2.83%
FY20231.35B1.36B-3.41%
FY20221.40B1.41B-3.23%

Common questions about Lam Research's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.